Found: 6 articles
Article | Edition |
---|---|
A.A. Gritskevich, T.P. Byteman, D.M. Monakov, I.G. Rusakov, S.V. Mishugin
PARP inhibitors in a personalized approach to the treatment of castration-resistant prostate cancer: clinical case
|
№11 / 2023 |
S.V. Khokhlova
Clinical case of treatment of patient with HRD-positive ovarian cancer
|
№11 / 2021 |
E.V. Lubennikova (1), L.G. Zhukova (2), O.O. Gordeeva (1), N.Ts. Drobot (1), A.V. Kuznetsov (3), I.P. Ganshina (1)
Olaparib – modern approach to the treatment of BRCA-associated HER2-negative metastatic breast cancer. Clinical experience
|
№7 / 2021 |
S.V. Khokhlova
Optimal treatment strategy for a patient with advanced ovarian cancer without deterioration in the quality of life: a clinical case
|
№12 / 2019 |
M.E. Abramov, E.I. Chichikov, E.I. Borisova, S.L. Gutorov
OLAPARIB – PROMISING DIRECTION IN THERAPY IN BRCA-ASSOCIATED TUMORS
|
№17 / 2017 |
A.S. Tyulyandina
PRESENT AND FUTURE OF TARGETED THERAPY AS FIRST-LINE TREATMENT OF OVARIAN CANCER
|
№8 / 2013 |